Bayer AG | |
Stock Exchange | Borsa Italiana |
EPS |
EUR7.73 |
Market Cap |
EUR65.6 B |
Shares Outstanding |
932.55 M |
Public Float |
- |
Bayer AG | |
Stock Exchange | Other OTC |
EPS |
$1.07 |
Market Cap |
$64.36 B |
Shares Outstanding |
932.55 M |
Public Float |
- |
Bayer AG ADR | |
Stock Exchange | Other OTC |
EPS |
$0.27 |
Market Cap |
$63.71 B |
Shares Outstanding |
3.73 B |
Public Float |
- |
Bayer AG | |
Stock Exchange | Xtend |
EPS |
HUF266.99 |
Market Cap |
HUF18.34 T |
Shares Outstanding |
826.95 M |
Public Float |
- |
Bayer AG ADR | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR0.21 |
Market Cap |
EUR56.7 B |
Shares Outstanding |
3.49 B |
Public Float |
- |
Bayer AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR0.85 |
Market Cap |
EUR56.62 B |
Shares Outstanding |
932.55 M |
Public Float |
932.55 M |
Bayer AG | |
Stock Exchange | Mexican Stock Exchange |
EPS |
MXN16.98 |
Market Cap |
MXN1.21 T |
Shares Outstanding |
932.55 M |
Public Float |
- |
Bayer AG | |
Stock Exchange | SIX Swiss Exchange |
EPS |
CHF1.02 |
Market Cap |
CHF63.41 B |
Shares Outstanding |
932.55 M |
Public Float |
- |
Address |
Kaiser-Wilhelm-Allee 1 Leverkusen Nordrhein-Westfalen 51368 Germany |
Employees | - |
Website | http://www.bayer.com |
Updated | 07/08/2019 |
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. |